CRT 2025
Valve and Structural
TAVR Hot Topics Sunday
Andreas Baumbach, MD, FRCP, FESC
Chair
Queen Mary University of London
London, England, United Kingdom
Disclosure information not submitted.
Toby Rogers, MD, PhD
Associate Professor of Medicine (Cardiology) and Scientific Lead for Structural Heart Disease
Georgetown University and MedStar Washington Hospital Center
Washington, District of Columbia, United States
Disclosure(s): Abbott: Consulting Fees (e.g., advisory boards) (Ongoing); Anteris: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Transmural Systems, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing)
Stephanie Sellers, PhD
Assistant Professor
University of British Columbia
Vancouver, British Columbia, Canada
Disclosure(s): Abbott: Consultant (Ongoing); Anteris: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Edward Lifesciences: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Excision Medical: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Stock options (Ongoing); Medtronic: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Vivitro Labs: Grant/Research Support (Ongoing)